GB201720543D0 - Dosage regime - Google Patents
Dosage regimeInfo
- Publication number
- GB201720543D0 GB201720543D0 GBGB1720543.6A GB201720543A GB201720543D0 GB 201720543 D0 GB201720543 D0 GB 201720543D0 GB 201720543 A GB201720543 A GB 201720543A GB 201720543 D0 GB201720543 D0 GB 201720543D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- dosage regime
- regime
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1720543.6A GB201720543D0 (en) | 2017-12-08 | 2017-12-08 | Dosage regime |
BR112019026564-3A BR112019026564A2 (en) | 2017-06-14 | 2018-06-14 | dosing regimens for administration of an anti-cd19 adc |
PCT/EP2018/065873 WO2018229222A1 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-cd19 adc |
EP18732041.1A EP3638373A1 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-cd19 adc |
MX2019015042A MX2019015042A (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-cd19 adc. |
CA3064804A CA3064804A1 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-cd19 adc |
US16/622,649 US11318211B2 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-CD19 ADC |
AU2018285562A AU2018285562B2 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-CD19 ADC |
KR1020197037482A KR102442736B1 (en) | 2017-06-14 | 2018-06-14 | Dosage regime for administration of anti-CD19 ADCs |
UAA202100090A UA127900C2 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-cd19 adc |
JP2019569479A JP7145891B2 (en) | 2017-06-14 | 2018-06-14 | Dosing Regimens for Administering Anti-CD19 ADCs |
US17/699,065 US11938192B2 (en) | 2017-06-14 | 2022-03-18 | Dosage regimes for the administration of an anti-CD19 ADC |
JP2022148738A JP2022191244A (en) | 2017-06-14 | 2022-09-20 | Dosage regimes for administration of anti-cd19 adc |
US17/938,193 US20230106885A1 (en) | 2017-06-14 | 2022-10-05 | Dosage regime |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1720543.6A GB201720543D0 (en) | 2017-12-08 | 2017-12-08 | Dosage regime |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201720543D0 true GB201720543D0 (en) | 2018-01-24 |
Family
ID=61007008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1720543.6A Ceased GB201720543D0 (en) | 2017-06-14 | 2017-12-08 | Dosage regime |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201720543D0 (en) |
-
2017
- 2017-12-08 GB GBGB1720543.6A patent/GB201720543D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201713653D0 (en) | Dosage regimen | |
GB201709652D0 (en) | Pharmaceutical compounds | |
GB201704965D0 (en) | Pharmaceutical compounds | |
GB201704714D0 (en) | Pharmaceutical compounds | |
GB201703881D0 (en) | Pharmaceutical compounds | |
IL269239A (en) | Pharmaceutical combination comprising ponesimod | |
GB201521217D0 (en) | Dosage regimens | |
GB201706806D0 (en) | Pharmaceutical compounds | |
GB201703876D0 (en) | Pharmaceutical combinations | |
GB201704966D0 (en) | Pharmaceutical compounds | |
PL3515413T3 (en) | Extended relief dosage form | |
IL269169A (en) | Novel dosage form | |
GB201607548D0 (en) | Solid dosage form | |
GB201720541D0 (en) | Dosage regime | |
GB201720542D0 (en) | Dosage regime | |
GB201720544D0 (en) | Dosage regime | |
GB201720543D0 (en) | Dosage regime | |
GB201710495D0 (en) | Dosage regime | |
GB201710496D0 (en) | Dosage regime | |
GB201710494D0 (en) | Dosage regime | |
GB201710493D0 (en) | Dosage regime | |
GB201709444D0 (en) | Dosage regime | |
GB201709441D0 (en) | Dosage regime | |
GB201709440D0 (en) | Dosage regime | |
GB201709439D0 (en) | Dosage regime |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |